Bausch & Lomb eyes global options as it cuts staff
This article was originally published in Clinica
Executive Summary
Eye care company Bausch & Lomb is to cut 7% of its workforce by consolidating its contact lens manufacturing operations. It has highlighted other areas where further savings can be made and has also authorised the repurchase of five million shares. The value of B&L's shares rose by nearly 11% to $60.7 on the news, with a trading volume of nearly double the daily average.